Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2026-02-22 @ 7:23 PM
Study NCT ID:
NCT02580058
Status:
COMPLETED
Last Update Posted:
2023-07-10
First Post:
2015-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-12
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-16
First Submit QC Date:
None
Study First Post Date:
2015-10-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-09-09
Results First Submit QC Date:
None
Results First Post Date:
2019-11-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-20
Last Update Post Date:
2023-07-10
Last Update Post Date Type:
ACTUAL